Literature DB >> 28712624

Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values.

Kim Rand-Hendriksen1, Juan Manuel Ramos-Goñi2, Liv Ariane Augestad3, Nan Luo4.   

Abstract

BACKGROUND: The conventional method for modeling of the five-level EuroQol five-dimensional questionnaire (EQ-5D-5L) health state values in national valuation studies is an additive 20-parameter main-effects regression model. Statistical models with many parameters are at increased risk of overfitting-fitting to noise and measurement error, rather than the underlying relationship.
OBJECTIVES: To compare the 20-parameter main-effects model to simplified, nonlinear, multiplicative regression models in terms of how accurately they predict mean values of out-of-sample health states.
METHODS: We used data from the Spanish, Singaporean, and Chinese EQ-5D-5L valuation studies. Four models were compared: an 8-parameter model with single parameter per dimension, multiplied by cross-dimensional parameters for levels 2, 3, and 4; 9- and 11-parameter extensions with handling of differences in the wording of level 5; and the "standard" additive 20-parameter model. Fixed- and random-intercept variants of all models were tested using two cross-validation methods: leave-one-out at the level of valued health states, and of health state blocks used in EQ-5D-5L valuation studies. Mean absolute error, Lin concordance correlation coefficient, and Pearson R between observed health state means and out-of-sample predictions were compared.
RESULTS: Predictive accuracy was generally best using random intercepts. The 8-, 9-, and 11-parameter models outperformed the 20-parameter model in predicting out-of-sample health states.
CONCLUSIONS: Simplified nonlinear regression models look promising and should be investigated further using other EQ-5D-5L data sets. To reduce the risk of overfitting, cross-validation is recommended to inform model selection in future EQ-5D valuation studies.
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Keywords:  EQ-5D; QALY; cross-validation; nonlinear; regression models; valuation

Mesh:

Year:  2017        PMID: 28712624     DOI: 10.1016/j.jval.2017.03.013

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  10 in total

1.  EQ-5D-5L Valuation for the Malaysian Population.

Authors:  Asrul Akmal Shafie; Annushiah Vasan Thakumar; Ching Jou Lim; Nan Luo; Kim Rand-Hendriksen; Faridah Aryani Md Yusof
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

2.  Assessment of health state utilities in dermatology: an experimental time trade-off value set for the dermatology life quality index.

Authors:  Gábor Ruzsa; Fanni Rencz; Valentin Brodszky
Journal:  Health Qual Life Outcomes       Date:  2022-06-03       Impact factor: 3.077

3.  Health-related quality of life among cancer survivors in rural China.

Authors:  Mingzhu Su; Xingxing Hua; Jialin Wang; Nengliang Yao; Deli Zhao; Weidong Liu; Yuewei Zou; Roger Anderson; Xiaojie Sun
Journal:  Qual Life Res       Date:  2018-10-29       Impact factor: 4.147

4.  EQ-5D-5L norms for the urban Chinese population in China.

Authors:  Zhihao Yang; Jan Busschbach; Gordon Liu; Nan Luo
Journal:  Health Qual Life Outcomes       Date:  2018-11-08       Impact factor: 3.186

5.  Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe.

Authors:  Dominik Golicki; Michał Jakubczyk; Katarzyna Graczyk; Maciej Niewada
Journal:  Pharmacoeconomics       Date:  2019-09       Impact factor: 4.981

6.  Sample Size and Model Prediction Accuracy in EQ-5D-5L Valuations Studies: Expected Out-of-Sample Accuracy Based on Resampling with Different Sample Sizes and Alternative Model Specifications.

Authors:  Tonya Moen Hansen; Knut Stavem; Kim Rand
Journal:  MDM Policy Pract       Date:  2022-03-07

7.  An EQ-5D-5L Value Set for Belgium.

Authors:  Nicolas Bouckaert; Irina Cleemput; Stephan Devriese; Sophie Gerkens
Journal:  Pharmacoecon Open       Date:  2022-08-04

8.  Estimating the EQ-5D-5L value set for the Philippines.

Authors:  Red Thaddeus D Miguel; Adovich S Rivera; Kent Jason G Cheng; Kim Rand; Fredrick Dermawan Purba; Nan Luo; Ma-Ann Zarsuelo; Anne Julienne Genuino-Marfori; Irene Florentino-Fariñas; Anna Melissa Guerrero; Hilton Y Lam
Journal:  Qual Life Res       Date:  2022-05-09       Impact factor: 3.440

Review 9.  Epigenetics Analysis and Integrated Analysis of Multiomics Data, Including Epigenetic Data, Using Artificial Intelligence in the Era of Precision Medicine.

Authors:  Ryuji Hamamoto; Masaaki Komatsu; Ken Takasawa; Ken Asada; Syuzo Kaneko
Journal:  Biomolecules       Date:  2019-12-30

10.  Valuation of EQ-5D-3l Health States in Slovenia: VAS Based and TTO Based Value Sets.

Authors:  Valentina Prevolnik Rupel; Andrej Srakar; Kim Rand
Journal:  Zdr Varst       Date:  2019-12-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.